{"rows":[{"id":1360,"title":"An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).","authors":"Donegan CJ, Daldegan-Bueno D, Sumner R, Menkes D, Evans W, Hoeh N, Sundram F, Reynolds L, Ponton R, Cavadino A, Smith T, Roop P, Allen N, Abeysinghe B, Svirskis D, Forsyth A, Bansal M, Muthukumaraswamy S","journal":"Pilot and feasibility studies","publication_date":"2023-10-05","publication_year":2023,"doi":"10.1186/s40814-023-01399-8","pubmed_id":"37798662","openalex_id":"https://openalex.org/W4387372869","source_url":"https://pubmed.ncbi.nlm.nih.gov/37798662/","substance_tags":"psilocybin","topic_tags":"Depression,Microdosing,Clinical Trial,Randomized Controlled Trial,Observational Study,Healthy Volunteers,Safety,Adverse Events","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:12","bibtex":null,"source_record_id":"PMID:37798662","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37798662/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37798662","source_url":"https://pubmed.ncbi.nlm.nih.gov/37798662/","doi":"10.1186/s40814-023-01399-8","pmid":"37798662","publication_date":"2023-10-05","importer_version":"2.1.3","text_redistributed":false}},{"id":467,"title":"Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial.","authors":"Richardson C, Chan C, Macgregor E, Hare C, Hannon B, Black S, Schneider E, Buchman D, Wang S, Rac V, Abrahamyan L, Huszti E, Nissim R, Li M, Zimmermann C, Hapke E, Rosenbaum D, Hales S","journal":"Pilot and feasibility studies","publication_date":"2025-10-28","publication_year":2025,"doi":"10.1186/s40814-025-01706-5","pubmed_id":"41152967","openalex_id":"https://openalex.org/W4415616586","source_url":"https://pubmed.ncbi.nlm.nih.gov/41152967/","substance_tags":"psilocybin","topic_tags":"Depression,End-of-Life Distress,Clinical Trial,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:55","bibtex":null,"source_record_id":"PMID:41152967","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41152967/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41152967","source_url":"https://pubmed.ncbi.nlm.nih.gov/41152967/","doi":"10.1186/s40814-025-01706-5","pmid":"41152967","publication_date":"2025-10-28","importer_version":"2.1.3","text_redistributed":false}}],"total":2,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Pilot and feasibility studies","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}